Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development
{{output}}
Conventional antimicrobial discovery relies on targeting essential enzymes in pathogenic organisms, contributing to a paucity of new antibiotics to address resistant strains. Here, by targeting a non-essential enzyme, Borrelia burgdorferi HtpG, to deliver leth... ...
